Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SUPN
SUPN logo

SUPN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Supernus Pharmaceuticals Inc (SUPN) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast SUPN stock price to rise
6 Analyst Rating
Wall Street analysts forecast SUPN stock price to rise
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 46.850
sliders
Low
55
Averages
61.33
High
65
Current: 46.850
sliders
Low
55
Averages
61.33
High
65
TD Cowen
Buy
maintain
$60 -> $65
AI Analysis
2026-02-25
Reason
TD Cowen
Price Target
$60 -> $65
AI Analysis
2026-02-25
maintain
Buy
Reason
TD Cowen raised the firm's price target on Supernus to $65 from $60 and keeps a Buy rating on the shares. The firm updated its model following Q4 results and encouragingly, management expects Onapgo supply constraint is now resolved, as the current supplier has increased production and a second supplier to be added in 2027.
Stifel
Annabel Samimy
Hold
maintain
$50 -> $55
2025-12-19
Reason
Stifel
Annabel Samimy
Price Target
$50 -> $55
2025-12-19
maintain
Hold
Reason
Stifel analyst Annabel Samimy raised the firm's price target on Supernus to $55 from $50 and keeps a Hold rating on the shares as part of a 2026 outlook note for the analyst's Biopharma coverage.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SUPN
Unlock Now

People Also Watch